Fluvoxamine
Fluvoxamine maleate extended-release capsules is a selective serotonin reuptake inhibitor (SSRI) indicated for the treatment of obsessive compulsive disorder (OCD) ( 1 ).
United States
$20
per month
India
$2
per month
You save
−89%save $18/mo · 89% cheaper
427.6K US scripts/yr$7.5M potential annual savings$8.4M US spend/yr
Drag to rotate · 3D structureC15H21F3N2O2
SMILES: COCCCC/C(=N\OCCN)/C1=CC=C(C=C1)C(F)(F)F
Compare the price
US price$20per month
India price$2per month
You save$1889% less
Based on 30 units per month. US $0.66 vs India $0.07 per unit.
Total over 1 periodSave $18$20 → $2
The bigger picture
Fluvoxamine is filled about 427.6K times a year under Medicare Part D. At the prices above, that works out to roughly:
Est. annual US spend
$8.4M
If sourced from India
$936.3K
Potential annual savings
$7.5M
−89%
Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.